{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:33:46Z","timestamp":1789536826743,"version":"build-2803163510"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100021177","name":"CDC Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021177","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014895","name":"Open Philanthropy Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.fertnstert.2024.07.004","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T11:58:08Z","timestamp":1720439888000},"page":"844-855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Trends and outcomes of fresh and frozen donor oocyte cycles in the United States"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8639-5546","authenticated-orcid":false,"given":"Caroline B.","family":"Braun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol E.","family":"DeSantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry M.","family":"Kissin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer F.","family":"Kawwass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2024.07.004_bib1","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.fertnstert.2018.09.020","article-title":"Innovations in assisted reproductive technologies: impact on contemporary donor egg practice and future advances","volume":"110","author":"Christianson","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.07.004_bib2","series-title":"2020 Assisted Reproductive Technology Fertility Clinic and National Summary Report","year":"2022"},{"key":"10.1016\/j.fertnstert.2024.07.004_bib5","first-page":"1395","article-title":"Reproductive Medicine and the Practice Committee for the Society for Assisted Reproductive Technology. Electronic address: ASRM@asrm.org. Guidance regarding gamete and embryo donation","volume":"115","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.07.004_bib6","first-page":"37","article-title":"Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline","volume":"99","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.07.004_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.fertnstert.2021.10.006","article-title":"Factors affecting live birth rates in donor oocytes from commercial egg banks vs. program egg donors: an analysis of 40,485 cycles from the Society for Assisted Reproductive Technology registry in 2016-2018","volume":"117","author":"Williams","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.07.004_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.rbmo.2011.05.014","article-title":"Oocyte cryopreservation for donor egg banking","volume":"23","author":"Cobo","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.07.004_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.fertnstert.2016.10.002","article-title":"Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013","volume":"107","author":"Crawford","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.07.004_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/AOG.0000000000003695","article-title":"Prevalence of a good perinatal outcome with cryopreserved compared with fresh donor oocytes","volume":"135","author":"Eaton","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.07.004_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1089\/jwh.2023.0267","article-title":"Multiple imputation of missing race\/ethnicity information in the National Assisted Reproductive Technology Surveillance System","volume":"33","author":"Zhang","year":"2024","journal-title":"J Women\u2019s Health (Larchmt)"},{"key":"10.1016\/j.fertnstert.2024.07.004_bib12","series-title":"Patient management and clinical recommendations during the Coronavirus (COVID-19) pandemic","year":"2020"},{"key":"10.1016\/j.fertnstert.2024.07.004_bib13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.fertnstert.2021.12.016","volume":"117","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.07.004_bib14","first-page":"2426","article-title":"Trends and outcomes for donor oocyte cycles in the United States, 2000-2010","volume":"310","author":"Kawwass","year":"2013","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.fertnstert.2024.07.004_bib15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.fertnstert.2018.01.002","article-title":"Electronic address: ASRM@asrm.org; Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion","volume":"109","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.07.004_bib16","first-page":"36","article-title":"Cost-effectiveness of preimplantation genetic testing for aneuploidy for fresh donor oocyte cycles","volume":"2","author":"Facadio","year":"2020","journal-title":"F S Rep"},{"key":"10.1016\/j.fertnstert.2024.07.004_bib17","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1093\/humrep\/deaa219","article-title":"Donor oocyte recipients do not benefit from preimplantation genetic testing for aneuploidy to improve pregnancy outcomes","volume":"35","author":"Doyle","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.07.004_bib19","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.fertnstert.2016.07.002","article-title":"Electronic address: ASRM@asrm.org; Ethics Committee of the American Society for Reproductive Medicine. Oocyte or embryo donation to women of advanced reproductive age: an Ethics Committee opinion","volume":"106","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.07.004_bib20","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/AOG.0b013e318269c0e9","article-title":"Trends and correlates of good perinatal outcomes in assisted reproductive technology","volume":"120","author":"Joshi","year":"2012","journal-title":"Obstet Gynecol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224005971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224005971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T20:34:13Z","timestamp":1762029253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028224005971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0015028224005971"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.07.004","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends and outcomes of fresh and frozen donor oocyte cycles in the United States","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92024 American Society for Reproductive Medicine, Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies","name":"copyright","label":"Copyright"}]}}